<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04672161</url>
  </required_header>
  <id_info>
    <org_study_id>20-06022242</org_study_id>
    <nct_id>NCT04672161</nct_id>
  </id_info>
  <brief_title>Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients</brief_title>
  <official_title>Education Intervention on Vaccination Adherence Among IBD Patients at Weill Cornell Medical Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A retrospective chart review and a six-month prospective outcome analysis aimed to evaluate&#xD;
      the efficacy of a vaccination education intervention and vaccination adherence among IBD&#xD;
      patients at Weill-Cornell Medical Center. It is hypothesized that a general vaccination&#xD;
      education campaign will improve vaccination adherence rates for all IBD patients.&#xD;
      Secondarily, it is hypothesized that an Human Papilloma Virus (HPV) vaccination intervention&#xD;
      targeted at high-risk IBD patients will increase vaccination adherence among these patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 4, 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Change in Vaccination Adherence in Patients</measure>
    <time_frame>Baseline; 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in qualitative attitude assessment on vaccination adherence and non-adherence as measured by self-reported 6-month questionnaire.</measure>
    <time_frame>Baseline; 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Crohn Disease (CD)</condition>
  <condition>Ulcerative Colitis (UC)</condition>
  <condition>Indeterminate Colitis</condition>
  <arm_group>
    <arm_group_label>Vaccine Education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the Experimental arm will receive a baseline educational intervention on vaccination following a vaccination history survey. Patients will be followed 6-months after the intervention to record prospective clinical data. Evidence of vaccination-status will be documented. Besides standard of care visits and testing, no additional procedures will be carried out for the purpose of this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Vaccine Education</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients randomized to the No Intervention arm will not receive the Vaccine Education. They will only complete the survey on their vaccination history.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vaccine Education</intervention_name>
    <description>A baseline educational intervention on vaccination and its role in the health maintenance of patients with IBD will be provided to all participants. Those on immunosuppressive therapies and/or those age 65 or older will also be offered the pneumonia vaccine educational intervention. Finally, patients aged 18-26 and those 27-45 who have never been vaccinated for HPV or those with high risk for HPV will additionally receive the HPV educational intervention.</description>
    <arm_group_label>Vaccine Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient at Weill-Cornell Medical Center with an in-person or virtual appointment&#xD;
             between March 1 - August 30, 2021.&#xD;
&#xD;
          -  Documentation of an IBD diagnosis (CD, UC, IC).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No documentation of an IBD diagnosis.&#xD;
&#xD;
          -  Pregnant or breastfeeding.&#xD;
&#xD;
          -  No scheduled appointment between March 1-August 30, 2021.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana J Lukin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vaccine</keyword>
  <keyword>HPV</keyword>
  <keyword>Vaccination</keyword>
  <keyword>IBD</keyword>
  <keyword>Inflammatory Bowel Diseases</keyword>
  <keyword>UC</keyword>
  <keyword>CD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

